Clinical and immunological efficiency of ribavirin in the treatment of hemorrhagic fever with renal syndrome
The study of clinical and immunological effectiveness of ribavirin in patients with hemorrhagic fever with renal syndrome was conducted. Found that the use of ribavirin in the early stages of the disease significantly reduces the duration of astheno vegetative and renal syndrome. The treatment with ribavirin decreased levels of specific antibodies in the in the slowly precipitating immune complexes, which indirectly indicates a decline in the replicative activity of Hantavirus.